Director, U.S. Oncology New Asset Planning

Working with Us
Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us.

Position Summary:

The Director, U.S. Oncology New Asset Planning is a senior commercial leader responsible for preparing Bristol Myers Squibb’s U.S. Oncology organization for the successful commercialization of multiple late‑stage and emerging solid tumor assets. This role sits at the critical intersection of Global Development and U.S. Commercial, ensuring early, disciplined, and integrated launch planning well ahead of formal product transitions.

The Director will lead U.S. strategic planning for a portfolio of pipeline assets expected to advance toward commercialization beginning in 2027 and beyond. This role will shape how new assets are integrated into the broader U.S. Oncology portfolio, including recommendations on launch team structure, resourcing models, investment prioritization, and functional readiness. As a core member of the U.S. Oncology Marketing Leadership Team, the Director will provide forward‑looking insight, strategic rigor, and enterprise perspective to ensure the organization is positioned to scale effectively as the portfolio expands.

Key Responsibilities:

• Lead U.S. commercial planning for multiple solid tumor pipeline assets transitioning from Global Development toward launch readiness.

• Develop early U.S. commercial hypotheses and strategic considerations (e.g., target populations, positioning considerations, sequencing within the broader portfolio) to inform enterprise decision‑making.

• Partner with Global teams to ensure U.S. commercial needs, realities, and timing are incorporated into development and transition planning.

• Define recommended U.S. launch models for new assets, including go‑to‑market approach, launch team structure, governance, and resourcing strategy.

• Partner with U.S. Oncology leadership to plan organizational implications of upcoming launches, including talent needs, sequencing of launches, and integration into existing brand teams.

• Lead cross‑asset planning to avoid silos and ensure a coordinated, portfolio‑first approach to commercialization.

• Provide U.S. commercial input into long‑range planning, budget development, and functional investment planning for pipeline assets.

• Partner with Finance and cross‑functional stakeholders to align assumptions, scenarios, and timing as assets progress toward launch.

• Support preparation of U.S. Oncology portfolio reviews, long‑range plans, and investment discussions with senior leadership.

• Serve as a key integrator across Marketing, Medical, Market Access, Sales, Forecasting, Finance, and other matrix functions to align early commercialization planning.

• Act as the U.S. Oncology point of accountability for coordinating early commercial discussions across multiple assets simultaneously.

• Establish clear ways of working between Global and U.S. teams to ensure smooth handoffs as assets approach launch.

• Represent new asset planning within the U.S. Oncology Marketing Leadership Team, bringing a forward‑looking, enterprise perspective.

• Support executive communications and leadership updates related to pipeline commercialization readiness and portfolio evolution.

• Build frameworks, tools, and processes that can be reused across assets to enable repeatable, scalable launch planning excellence.

Key Qualifications & Experience:

• 10+ years experience in U.S. oncology commercial strategy, marketing, or launch planning, ideally with exposure to pipeline or pre‑launch assets.

• Proven ability to operate in ambiguity, synthesize complex inputs, and translate strategy into actionabl